Exane Derivatives’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $41 | Sell |
10
-10,223
| -100% | -$41.9K | ﹤0.01% | 745 |
|
|
2022
Q1 | $118K | Buy |
10,233
+2,347
| +30% | +$27K | 0.03% | 445 |
|
|
2021
Q4 | $78.7K | Buy |
+7,886
| New | +$78.7K | 0.02% | 452 |
|
|
2021
Q3 | – | Sell |
-5,167
| Closed | -$100K | – | 1059 |
|
|
2021
Q2 | $100K | Hold |
5,167
| – | – | 0.02% | 524 |
|
|
2021
Q1 | $110K | Sell |
5,167
-1,007
| -16% | -$21.4K | 0.03% | 399 |
|
|
2020
Q4 | $184K | Hold |
6,174
| – | – | 0.05% | 311 |
|
|
2020
Q3 | $134K | Buy |
6,174
+214
| +4% | +$4.64K | 0.04% | 236 |
|
|
2020
Q2 | $133K | Hold |
5,960
| – | – | 0.04% | 235 |
|
|
2020
Q1 | $90.7K | Buy |
+5,960
| New | +$90.7K | 0.03% | 275 |
|